|
| Status |
Public on Sep 14, 2011 |
| Title |
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis |
| Organism |
Homo sapiens |
| Experiment type |
Genome variation profiling by SNP array
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
21876152 |
| Submission date |
Nov 05, 2010 |
| Last update date |
Dec 06, 2018 |
| Contact name |
Nina Ilic |
| E-mail(s) |
nina_ilic@dfci.harvard.edu
|
| Phone |
617 632 6293
|
| Fax |
617 632 4770
|
| Organization name |
Dana-Farber Cancer Institute
|
| Department |
Cancer Biology
|
| Lab |
Roberts Laboratory-SM912
|
| Street address |
44 Binney Street
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02115 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL571 |
[HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array |
| GPL3720 |
[Mapping250K_Sty] Affymetrix Mapping 250K Sty2 SNP Array |
|
| Samples (12)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE25170 |
MYC drives resistance to PI3K/mTOR targeted inhibition (Sty SNP array) |
| GSE25172 |
MYC drives resistance to PI3K/mTOR targeted inhibition (gene expression) |
|
| Relations |
| BioProject |
PRJNA134431 |
Less...
More...